Advertisements



Marinus Pharmaceuticals provides pipeline update

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 30th, 2020

Marinus Pharmaceuticals to hold a pipeline update webinar

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 29th, 2020

Marinus Pharmaceuticals Provides Business Reports Update and 2019 Financial Results

RADNOR, Pa., March 16, 2020 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today provided a busi.....»»

Category: earningsSource: benzingaMar 16th, 2020

Marinus Pharmaceuticals provides update on orphan seizure programs

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 9th, 2019

Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter Financial Results

 Positive Phase 2 IV ganaxolone data in RSE .....»»

Category: earningsSource: benzingaNov 6th, 2019

Mid-Afternoon Market Update: Crude Oil Down 1%; Marinus Pharmaceuticals Shares Spike Higher

Toward the end of trading Thursday, the Dow traded down 0.03% to 26961.38 while the NASDAQ fell 0.46% to 8040.00. The S&P also fell, dropping 0.06% to 2,983.08. Leading .....»»

Category: earningsSource: benzingaSep 26th, 2019

Marinus Pharmaceuticals Provides Business Update and 2018 Financial Results

RADNOR, Pa., March 11, 2019 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), a.....»»

Category: earningsSource: benzingaMar 11th, 2019

Marinus Pharmaceuticals Provides Business Update and Third Quarter 2018 Financial Results

RADNOR, Pa., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) ("Marinus" or "Company").....»»

Category: earningsSource: benzingaOct 29th, 2018

Here"s Why Spectrum Pharmaceuticals Rose 21.5% in November

The company announced third-quarter 2018 earnings and a pipeline update, but investors weren't happy with results from an important trial announced in early December......»»

Category: topSource: foxnewsDec 10th, 2018

Mid-Day Market Update: Remark Holdings Falls After Q1 Results; Corvus Pharmaceuticals Shares Jump

Midway through trading Tuesday, the Dow traded down 0.51.....»»

Category: earningsSource: benzingaJul 7th, 2020

Mid-Day Market Update: Remark Holdings Falls After Q1 Results; Corvus Pharmaceuticals Shares Jump

Midway through trading Tuesday, the Dow traded down 0.51% to 26153.90 while the NASDAQ rose 0.80% to 10,517.24. The S&P also rose, gaining 0.11% to 3,183.22. read more.....»»

Category: blogSource: benzingaJul 7th, 2020

Mid-Day Market Update: Sino-Global Shipping Falls After Q3 Results; Corvus Pharmaceuticals Shares Jump

Midway through trading Tuesday, the Dow traded down 0.51% to 26153.90 while the NASDAQ rose 0.80% to 10,517.24. The S&P also rose, gaining 0.11% to 3,183.22. read more.....»»

Category: blogSource: benzingaJul 7th, 2020

Marinus Pharmaceuticals initiated with an Outperform at Cowen

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 1st, 2020

Marinus Pharmaceuticals price target raised to $9 from $6 at H.C. Wainwright

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 1st, 2020

Mid-Day Market Update: NASDAQ Rises Over 100 Points; Verrica Pharmaceuticals Shares Plummet

Midway through trading Tuesday, the Dow traded down 0.01% to 25595.02 while .....»»

Category: earningsSource: benzingaJun 30th, 2020

Marinus Pharmaceuticals says first patient enrolled in Phase 2 TSC trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 30th, 2020

Marinus Pharmaceuticals expects CDD Phase 3 trial results in Q3

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 30th, 2020

Marinus Pharmaceuticals on track to begin SE Phase 3 trial in Q3

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 30th, 2020

VistaGen Therapeutics Reports Fiscal Year 2020 Results and Provides CNS Pipeline Update

SOUTH SAN FRANCISCO, Calif., June 29, 2020 /PRNewswire/ -- VistaGen Therapeutics (NASDAQ:VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for anxiety, depression and.....»»

Category: earningsSource: benzingaJun 29th, 2020

Mid-Afternoon Market Update: Dow Jumps 475 Points; Intercept Pharmaceuticals Shares Slide

Toward the end of trading Monday, the Dow traded up 1.9% to 25,490 while the NASDAQ rose 0.81% to 9,836.65. The S&P also rose, gaining 1.07% to 3,041.17. read more.....»»

Category: blogSource: benzingaJun 29th, 2020

Mid-Day Market Update: Crude Oil Up 1%; Xeris Pharmaceuticals Shares Plummet

Midway through trading Thursday, the Dow traded down 0.31% to 25365.94 while the NASDAQ fell 0.19% to 9890.79. The S&P also fell, dropping 0.34% to 3039.82. The U.S. has the highest number of coronavirus cases and deaths i.....»»

Category: earningsSource: benzingaJun 25th, 2020